Terapia Génica en Enfermedad de Parkinson
PARKBA SAL
Instituto de Investigación Sanitaria del Principado de Asturias
Oviedo, EspañaPublikationen in Zusammenarbeit mit Forschern von Instituto de Investigación Sanitaria del Principado de Asturias (2)
2020
-
Expression of GPR55 and either cannabinoid CB1 or CB2 heteroreceptor complexes in the caudate, putamen, and accumbens nuclei of control, parkinsonian, and dyskinetic non-human primates
Brain Structure and Function, Vol. 225, Núm. 7, pp. 2153-2164
2019
-
Targeting CB1 and GPR55 Endocannabinoid Receptors as a Potential Neuroprotective Approach for Parkinson’s Disease
Molecular Neurobiology, Vol. 56, Núm. 8, pp. 5900-5910